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Axonal injuries at the interface between central and peripheral nervous system, such as ventral root avulsion (VRA), induce
important degenerative processes,mostly resulting in neuronal andmotor function loss. In the present work, we have compared two
different fibrin sealants, one derived from human blood and another derived from animal blood and Crotalus durissus terrificus
venom, as a promising treatment for this type of injury. Lewis rats were submitted to VRA (L4–L6) and had the avulsed roots
reimplanted to the surface of the spinal cord, with the aid of fibrin sealant. The spinal cords were processed to evaluate neuronal
survival, synaptic stability, and glial reactivity, 4 and 12 weeks after lesion. Sciatic nerves were processed to investigate Schwann
cell activity by p75NTR expression (4 weeks after surgery) and to count myelinated axons and morphometric evaluation (12 weeks
after surgery). Walking track test was used to evaluate gait recovery, up to 12 weeks.The results indicate that both fibrin sealants are
similarly efficient. However, the snake-derived fibrin glue is a potentially safer alternative for being a biological and biodegradable
product which does not contain human blood derivatives. Therefore, the venom glue can be a useful tool for the scientific
community due to its advantages and variety of applications.
1. Introduction
Spinal roots injuries constitute an importantmedical problem
and usually affect the brachial plexus in consequence of high
energy trauma, causingmotor, sensibility, and autonomic loss
[1–5]. The brachial plexus injury is extremely debilitating for
the patient because, besides significant upper limb function
loss, it causes an everyday tasks limitation [6], which can
result in unemployment, depression, and in some cases even
suicide [6]. Such medical problem is typically associated
with young patients following motorcycle and radical sports
accidents [1].
Root avulsion results in interruption of neurotrophic
factors flow towards severed motoneurons, vascular trauma,
and excitotoxicity, leading to drastic 80% death during the
following 2 weeks after injury [7–9]. Together with neurode-
generation, synaptic changes in the spinal cord microen-
vironment cause expressive reduction of complexity and
decreased number of presynaptic boutons apposing to surviv-
ing motoneurons [10–15]. Astroglial and microglial reactivity
[16], together with the presence of meningeal fibroblasts [17],
contribute to the formation of the so-called glial scar, min-
imizing chances of target organ reinnervation, culminating
with an irreversible state of paralysis [15].
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Currently, the repair of spinal root injuries is a highly
delicate challenge, being particularly uncertain because of
the risk of additional damage to the spinal cord, since the
procedure is based on pia mater suturing [1]. Nevertheless,
the surgical reimplantation of injured ventral roots has been
shown to be efficient and neuroprotective [18]. In patients, it
may be considered promising treatment to partially recover
motor and autonomic functions, as well as reduce untreatable
neuropathic pain [1, 19].
Due to the fact that direct pial suture is not always possible
because of tissue loss, alternative apposition and fixation of
avulsed roots with surgical adhesives have been proposed.
Among available sealants, fibrin glue is biocompatible and
permissive to axonal regeneration. They are produced with
constituents of human blood [20] that, when combined, form
a fibrin bioactive matrix with adhesive and hemostatic pro-
prieties mimicking the final steps of the clotting cascade [21].
The use of such sealants on clinical practice is already known
and widely discussed. Among many different applications,
neurosurgery is of particular interest, due to the specific need
of repair stability and absence of side effects [22].
In order to avoid potential adverse effects of using
human derived components, such as disease transmission,
researchers from CEVAP, UNESP, Brazil, produced a new
fibrin sealant, in which the thrombin fraction is substituted
by a protein from Crotalus durissus terrificus venom. The
venom has thrombin-like fraction demonstrated by Nahas
et al. [23] and isolated by Raw et al. [24]. The thrombin-
like fraction has the ability to transform the fibrinogen
directly into fibrin, forming a stable clot [25–29]. Also,
bubaline fibrinogen substitutes the human counterpart [26].
As an alternative to commercial glues, such new biological
product is more flexible in terms of formulation matching
specific surgical needs, what can be an advantage to the
commercial equivalent. Additionally, its production costs are
lower, allowing broader application [26, 29].
Nevertheless, to date there is no comparative study,
indicating that CEVAP’s sealant performs equally well to
currently marketed similars. In this regard, the present study
demonstrates that root implantation, on the site of injury, can
be carried out in a reproducible way with both commercial
and nonhuman derived sealants.
2. Material and Methods
2.1. Experimental Animals. Thepresent study was carried out
using ten-week-old adults female Lewis rats (LEW/HsdUnib)
weighting around 200 g. The animals were obtained from
the Multidisciplinary Center for Biologic Research (CEMIB)
at the University of Campinas (UNICAMP), Sa˜o Paulo,
Brazil. The experiments were conducted according to the
ethical standards for animal experimentation and were
approved by the Ethical Committee for Animal Use (CEUA,
UNICAMP, protocol 3064-1). Animals were subjected to
unilateral ventral root avulsion and reimplantation at the
lumbar intumescence (L4, L5, and L6 right side; 𝑛 = 5 for
each experimental group and technique). The contralateral
roots to avulsion were used as the control for result analysis.
The following experimental groups were constituted: (I)
ventral root avulsion alone; (II) avulsion and reimplantation
of ventral roots with fibrin sealant produced from the
Crotalus durissus terrificus venom (CEVAP); (III) avulsion
and reimplantation of ventral roots with commercial fibrin
sealant Tissucol (Baxter AG, Vienna, Austria).
2.2. Ventral Root Avulsion (VRA). The rats were anesthetized
by a combination of xylazine chlorhydrate (Anasedan,
10mg/Kg, Sespo Indu´stria e Come´rcio, Paul´ınia/SP, Brazil)
and ketamine hydrochloride (Dopalen, 50mg/Kg, Sespo
Indu´stria e Come´rcio, Paul´ınia/SP, Brazil) and subjected to
unilateral avulsion of the lumbar ventral roots as previously
described [2, 30–34]. Unilateral avulsion was performed at
the L4–L6 lumbar ventral roots after unilateral laminectomy
(right side). A longitudinal incision was made to open the
dural sac, and the denticulate ligament was dissected. Finally,
the ventral and dorsal roots were carefully separated so that
the ventral roots associated with the lumbar intumescence
could be identified and avulsed with fine forceps (Dumont,
Switzerland, Part number 11242-40). After lesioning, the
roots and spinal cord were returned to their original position,
and the musculature, fascia, and skin were sutured in lay-
ers. Chlorhydrate of tramadol (Germed Farmaceˆutica Ltda,
Hortolaˆndia/SP, Brazil) was administrated by gavage after
the surgical procedures (20mg/kg) and 2.5mg/day soluble in
water during 5 days. The animals were housed under a 12-
hour light/dark cycle and controlled temperature (23∘C), with
free access to food and water.
2.3. Roots Reimplantation and Fibrin Sealants. In the VRA +
sealant groups, the roots were replaced at the exact point of
detachment, on the ventral surface of the lumbar spinal cord
at the avulsion site with the aid of fine forceps. The fibrin
sealant derived from snake venom was kindly supplied by
the Center for the Study of Venoms and Venomous Animals
(CEVAP) of UNESP; its constituents and instructions for
use are stated in the respective patents (registration numbers
BR1020140114327 and BR1020140114360). This sealant was
composed of three separate solutions and homogenized
immediately before use in a total final volume of 6mL: (1)
fibrinogen derived from bubaline blood (3mL), (2) calcium
chloride (2mL), and (3) a thrombin-like enriched fraction
(1mL) [25–29].
During surgical repair of the avulsed roots, the first
two components were applied and the avulsed roots were
returned to their original sites.The third component was then
added for polymerization. The reimplanted roots were then
gently pulled from the spinal cord, and the stability of the
fixation was observed to evaluate the success of the repair,
while the commercial fibrin sealant utilized was Tissucol
(Baxter AG, Vienna, Austria). This sealant is a lyophilized
concentrate of human proteins and composed by 4 compo-
nents: (1) lyophilized fibrinogen; (2) aprotinin solution; (3)
lyophilized thrombin; and (4) calcium chloride solution. At
the time of use, the components were previously thawed,
reconstituted,mixed, and applied following themanufacturer
instructions.
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2.4. Functional Analysis. For the gait recovery analysis,
the CatWalk system was used (CatWalk, Noldus Inc.,
Wageningen, Netherlands; http://www.noldus.com/animal-
behavior-research/products/catwalk). In this setup, the ani-
mal crosses a walkway with an illuminated glass floor. A
green LED illuminates the long edge of the floor so that the
light highlights only the places where the animal’s paws touch
the glass surface. By illuminating the footprints, the plantar
surfaces were captured by a high-speed video camera (Fuji-
non DF6H-1B) equipped with a wide-angle lens (8.5mm,
Fujicon Corp., China) positioned underneath the walkway.
The paw prints are automatically recorded and classified by
the software and were recorded before and after the VRA.
Postoperative CatWalk data were collected weekly for 12
weeks. The peroneal functional index (PFI) was calculated as
the distance between the third toe and hind limb pads (print
length) and the distance between the first and fifth toes (print
width). Measurements of these parameters were obtained
from the right (lesioned) and left (unlesioned) paw prints,
and the values were calculated using the following formula
by Bain et al. [35]: PFI = 174.9 × ((EPL − NPL)/NPL)) + 80.3
× ((ETS − NTS)) – 13.4, where N is normal or nonoperated
side; E is experimental or operated side; PL is print length;
TS is total toe spread or distance between first and fifth toe.
The pressure exerted on the platform by individual paws was
also evaluated.The CatWalk data from each day of evaluation
were expressed as an ipsi/contralateral ratio.
2.5. Specimen Preparation. The animals were anaesthetized
with an overdose of a combination of xylazine chlorhydrate
(Anasedan, 10mg/Kg, Sespo Indu´stria e Come´rcio, Paul´ınia/
SP, Brazil) and ketamine hydrochloride (Dopalen, 50mg/Kg,
Sespo Indu´stria e Come´rcio, Paul´ınia/SP, Brazil) and the
vascular system was rinsed by transcardial perfusion with
0.1M saline phosphate buffer (pH 7.38) followed by fixative
solution. For myelin fibers counting and morphometry (sci-
atic nerve regeneration analysis), the rats were killed and
fixed by transcardial perfusion with 2,5% glutaraldehyde and
1% paraformaldehyde in 0,1M phosphate buffer (pH 7,38).
A 10mm midthigh segment of the sciatic nerve (ipsi and
contralateral) was exposed, dissected, and stored in the same
fixative solution, for 24 hours at 22∘C. The fragments were
washed with 0.1M saline phosphate buffer (pH 7.38) and
postfixed for 3 hours in osmium tetroxide solution 1% diluted
in phosphate buffer (pH 7.38). After the postfixation the
fragments were washed in distilled water and dehydrated
through ethanol series and acetone (for 60 minutes) and
embedded in Durcupan ACM (Fluka, Steinheim, Switzer-
land). The specimens were trimmed and semithin sections
(0.5 𝜇m) were obtained in ultramicrotome (Leica Ultracut
UCT Ultramicrotome). For neuronal survival counting and
immunohistochemical evaluation (𝑛 = 5 for each group) the
rats were killed and fixed by transcardial perfusion with
10% formaldehyde in 0.1M phosphate buffer (pH 7.38). The
lumbar intumescence and sciatic nerves (ipsi and contralat-
eral) were exposed, dissected out, postfixed for 24 hours
at 22∘C in the same fixative solution, and then washed in
0.1M phosphate buffer (pH 7.38) and subjected to 10, 20,
and 30% sucrose in 0.1M PB for 24 h each, before freezing.
The specimens were embedded in Tissue-TekO.C.T. (Sakura
Finetek USA, Inc., Torrance, CA USA) and frozen at −33∘ to
−40∘C. Transverse sections (12𝜇m thickness) of spinal cords
and longitudinal sections (12 𝜇m thickness) of sciatic nerves
were obtained in cryostat (Microm HM 525, MICROM
International GmbH-Walldorf, Germany) and transferred
to gelatin-coated slides and dried at room temperature for
30min before being stored at −20∘C until the moment of use.
2.6. Counting of Myelinated Axons and Morphometric Anal-
ysis. The sciatic nerves were processed for myelinated
axon counting and morphometric evaluation by transverse
semithin sections (0.5𝜇m thick), stained in Sudan black
(0.7% in 70% alcohol) solution, and examined using a bright
field microscope Leica CTR 6500 (Leica Microsystems
CMS GmbH) and Adobe Photoshop CS5 (Adobe Systems)
software. The analyses were performed by sampling at least
30% of each nerve cross section (magnification of 1,000x),
generating approximately 12 images per animal. Sampling
bias was avoided by spreading themicrographs systematically
over the entire cross section, according to the procedure
proposed byMayhew and Sharma [36].The images were used
for counting the total number of myelinated axons in each
specimen. For themorphometric analysis, two sampled fields
in each nerve (magnification of 1,000x) were utilized. The
images were converted to black and white, so that any back-
ground artefacts would not bemeasured, including fibers that
were partly captured. The myelinated axons were identified
and the measurements were carried out automatically, after
calibration.Themeasurements provided weremyelin sheath’s
area, perimeter, and smaller diameter of each myelinated
fiber. These values were used to calculate the myelinated
axons diameter, myelin thickness (fiber diameter − axon
diameter/2) and “𝑔” ratio (axon diameter/fiber diameter).
The data are represented as the mean ± standard error (SE)
for each group.
2.7. Motoneuron Survival. Transverse cryostat sections of
the spinal cords were stained in aqueous toluidine blue
(1mg/100mL) for 3–5minutes at room temperature.The sec-
tionswere washedwith distilledwater, dehydrated in crescent
series of alcohol and xylene, and mounted with Entellan
(Merck KGaA, Darmstadt, Germany). The motoneurons
present in the lateral motor nucleus of the anterior horn
on the ipsilateral side (injured) and contralateral side (not
injured) were identified (based on their morphology, size,
and location in the dorsolateral lamina IX) and counted
in alternate sections of each specimen in about 12 sections
with a 192 𝜇m space between them. Only the cells with
visible nucleus andnucleoluswere counted.Thepercentage of
surviving cells was analyzed by the ratio of absolute numbers
of motoneurons, counted per section, on the lesioned and
nonlesioned sides, respectively, and multiplying the result
by 100. Abercrombie’s formula [37] was used to correct the
duplicate counting of neurons: 𝑁 = 𝑛𝑡/(𝑡 + 𝑑), where
“𝑁” is the corrected number of counted neurons, “𝑛” is the
number of counted cells, “𝑡” is the thickness of the sections,
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Table 1: Primary antibodies used for the immunofluorescence assay.
Each antibody is followed by the supplier, host animal, product code,
and concentration used.
Antibody Supplier Hostanimal
Product
code Concentration
Synaptophysin Millipore Mouse MAB5258 1 : 1,500
GFAP Abcam Rabbit AB779 1 : 250
IBA-1 Wako Rabbit 019-19741 1 : 2,000
S-100 Dako Rabbit Z0311 1 : 2,000
p75NTR Santa Cruz Goat Sc6188 1 : 250
and “𝑑” is the average diameter of neuronal nuclei. As the
difference in the size affects the cells number significantly, “𝑑”
value was calculated for each experimental group (ipsilateral
and contralateral) specifically. In order to this, the nuclear
diameter of 15 randomly chosen motoneurons from each
group was measured (ImageTool software, version 3.00, The
University of Texas Health Science Center, TX) and the mean
value calculated. The data are represented as the mean ±
standard error (SE) for each group.
2.8. Immunofluorescence. Transverse cryostat sections of the
spinal cords and longitudinal cryostat sections of the sciatic
nerves were acclimatized, washed in 0.1M phosphate buffer
(pH 7.38, 3 times of 5 minutes each), and incubated for
45min in a 3% BSA (bovine serum albumin) solution in
0.1M phosphate buffer (pH 7.38) followed by incubation with
the primary antibodies (Table 1). The primary antibodies
were diluted in a solution containing 1% BSA (bovine serum
albumin) and 2% Triton in 0.1M phosphate buffer (pH 7.38).
All sections were incubated for 4 hours at room tempera-
ture in a moist chamber. After rinsing in PB, the sections
were incubated with a Cy3-conjugated secondary antiserum
(1 : 250, Jackson Immunoresearch,West Grove, PA, USA) and
diluted in 1% BSA and 0.2% Triton in 0.1M PB (pH 7.38) for
45minutes in amoist chamber at room temperature.The sec-
tions were then rinsed in 0.1M PB (pH 7.38) and mounted in
a mixture of glycerol/PBS (3 : 1) and observed in fluorescence
microscope LeicaDM5500Bmicroscope coupledwith a Leica
DFC345 FX camera (LeicaMicrosystemsCMSGmbH) utiliz-
ing rhodamine filters (CY3). For quantitative measurements,
three representative images of the spinal cord (L4–L6 at
lamina IX, ventral horn) and sciatic nerve from each animal
were captured at a final magnification of 200x. For the quan-
tification, the integrated density of pixels, which represents
the intensity of labeling, was measured utilizing the ImageJ
1.33u (National Institutes of Health, USA) software. For the
analysis of anti-glial fibrillary acidic protein (GFAP) and anti-
ionized calciumbinding adaptormolecule 1 (Iba1) antibodies,
the integrated density of pixels wasmeasured in the lamina IX
ventrolateral, as described by Oliveira et al. [38] and Freria
et al. [39]. For analysis of synaptophysin immunolabeling,
the integrated density of pixels was systematically measured
in eight representative areas surrounding each motoneuron
located at lamina IX, in the anterior horn of the spinal
cord, according to Oliveira et al. [38]. The proportion of
integrated density of pixels was calculated for each animal
and then as the mean value for each spinal cord. The data
are represented as the mean ± standard error (SE) for each
group.
2.9. Statistical Analysis. Statistical analysis was performed
with GraphPad Prism 4.0 software. The neuronal survival,
myelinated fiber counting, and immunofluorescence data
were evaluated via “one-way analysis of variance.” Data from
the functional analysis (walking track test) andmorphometry
of myelinated fibers were evaluated via “two-way analysis
of variance.” “Bonferroni Multiple Comparison Test” and
“Newman-Keuls Multiple Comparison Test” were used to
identify intergroup differences. The data are presented as
the mean ± standard error (SE) and the differences between
groups were considered significant when the 𝑃 value was
>0.05 (∗), >0.01 (∗∗), and >0.001 (∗ ∗ ∗).
3. Results
3.1. Neuroprotective Effects after Root Reimplantation. Neu-
ronal survival after VRA and reimplantation was evaluated
by the counting of motoneurons present at lamina IX of
the ventral horn, in the ipsilateral side as compared to
contralateral side, 4 and 12 weeks after lesion (Figure 1). No
statistical differences regarding motoneuron numbers in the
contralateral side, in the different experimental conditions,
were observed. Based on that, all results were expressed as
percentage of surviving motoneurons in comparison to the
contralateral side. Four weeks after lesion, a significant loss of
motoneurons could be observed in theVRA group, due to the
injury (Figure 1(a)). Contrarily, the reimplanted groups dis-
played statistically higher number of surviving motoneurons
(Figures 1(e), 1(i), and 1(m)). Also, no differences between the
reimplanted groups were observed (VRA Only: 37.59 ± 3.40;
VRA + Venom Glue: 66.27 ± 5.63; VRA + Commercial Glue:
70.93 ± 5.21; mean ipsi/contralateral ratio ± SE; F
2,12
= 13.86;
P value = 0.0008; 𝑁 = 5 per group). Such neuroprotective
effect remained up to 12weeks after lesion, when the neuronal
survival in the reimplanted groups was statistically superior
to the VRAOnly (Figures 1(c), 1(g), and 1(k)). Once again, no
differences between the reimplanted groups were observed
(VRA Only: 27.75 ± 3.42; VRA + Venom Glue: 53.64 ± 6.43;
VRA+Commercial Glue: 51.57±7.24; mean ipsi/contralateral
ratio ± SE; F
2,12
= 5.883; P value = 0.016;𝑁 = 5 per group).
3.2. Reduction of Synaptic Elimination after Reimplantation.
Synaptic activity changes after root avulsion and reimplanta-
tion were evaluated in the sciatic motor nucleus in the ventral
horn of the spinal cord, by synaptophysin immunolabeling, 4
and 12 weeks after the injury (Figure 2). In both experimental
survival times analyzed, the synaptophysin immunoreactivity
showed higher synaptic density in the contralateral side than
the ipsilateral side of avulsed animals. Such expression was
drastically decreased in axotomized motoneurons surface
in animals without reimplantation, indicating a significant
decrease of complexity of propriospinal networks following
lesion. In contrast, in the reimplanted groups, the repair
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Figure 1: Nissl-stained spinal cord transverse sections at lamina IX illustrating the neuroprotective effect of root reimplantation on
motoneurons, 4 and 12 weeks following ventral root avulsion and repair. Note the decreased number of motoneurons, ipsilateral to the lesion.
Also, observe the improvement of neuronal survival in the reimplanted groups. (a-b, e-f, and i-j) Ipsilateral and contralateral sides, 4 weeks
after lesion. (c-d, g-h, and k-l) Ipsilateral and contralateral sides, 12 weeks after lesion. (m) Percentage of neuronal survival 4 and 12 weeks
following ventral root avulsion and reimplantation. The reimplanted groups displayed a significantly increased neuronal survival, 4 and 12
weeks after lesion. Scale bar = 50 𝜇m. Mean ± SE. ∗𝑝 < 0.05; ∗∗𝑝 < 0.01.
resulted in preservation of synaptophysin immunoreactivity,
particularly in the immediate vicinity of the motoneurons.
Statistical analysis revealed no differences between the reim-
planted groups (4 weeks after lesion: VRA Only: 0.41 ± 0.04;
VRA + Venom Glue: 0.68 ± 0.06; VRA + Commercial Glue:
0.72±0.04; mean ipsi/contralateral ratio ± SE; F
2,12
= 13.47; P
value = 0.0009;𝑁 = 5 per group); 12 weeks after lesion: VRA
Only: 0.46 ± 0.05; VRA + Venom Glue: 0.72 ± 0.02; VRA +
Commercial Glue: 0.77 ± 0.03; mean ipsi/contralateral ratio ±
SE; F
2,6
= 16.13; P value = 0.0016;𝑁 = 3 per group).
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Figure 2: Immunohistochemical analysis of the spinal cord ventral horn stained with antisynaptophysin, 4 and 12 weeks, following ventral
root avulsion and repair. A significant preservation of synaptophysin immunoreactivity was observed in both reimplanted groups. (a-b, e-f,
and i-j) Ipsilateral and contralateral sides, 4 weeks after lesion. (c-d, g-h, and k-l) Ipsilateral and contralateral sides, 12 weeks after lesion. (m)
Synaptic covering, obtained by the ratio IL/CL (ipsi/contralateral sides) of the integrated density of pixels at lamina IX, 4 weeks after lesion.
(n) Synaptic covering, obtained by the ratio IL/CL (ipsi/contralateral sides) of the integrated density of pixels at lamina IX, 4 weeks after
lesion. Observe the significant reduction of synaptic elimination in both groups repaired with fibrin sealant. Scale bar = 50 𝜇m. Mean ± SE.
∗∗𝑝 < 0.01.
3.3. Glial Reactivity Is Not further Enhanced by Reimplanta-
tion. Glial reactivity after ventral root avulsion and reim-
plantation was evaluated in the ventral horn of the spinal
cord, by immunofluorescence analysis, 4 and 12 weeks after
lesion. Immunoreactivity against GFAP was used to analyze
the degree of astroglial reactivity after lesion (Figure 3) while
Iba-1 immunoreactivity was used to assess the degree of
microglial reactivity (Figure 4). Four weeks after lesion, the
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Figure 3: Immunohistochemical analysis of the spinal cord ventral horn stained with glial fibrillary acid protein (GFAP), 4 and 12 weeks
following ventral root avulsion and repair. No significantly further increase in astrogliosis after reimplantation was observed. (a-b, e-f, and
i-j) Ipsilateral and contralateral sides, 4 weeks after lesion. (c-d, g-h, and k-l) Ipsilateral and contralateral sides, 12 weeks after lesion. (m)Mean
integrated density of pixels obtained ipsi and contralateral to the lesion side, 4 weeks after injury. (n)The ratio IL/CL (ipsi/contralateral sides)
of the integrated density of pixels at lamina IX, 4 weeks after lesion. (o) Mean integrated density of pixels obtained ipsi and contralateral to
the lesion side, 12 weeks after injury. (p) The ratio IL/CL (ipsi/contralateral sides) of the integrated density of pixels at lamina IX, 12 weeks
after lesion. Scale bar = 50𝜇m. Mean ± SE.
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Figure 4: Immunohistochemical analysis of the spinal cord ventral horn stainedwith ionized calcium binding adaptor protein (Iba1), 4 and 12
weeks following ventral root avulsion and repair. No significantly further increase in microgliosis after reimplantation was observed. (a-b, e-f,
and i-j) Ipsilateral and contralateral sides, 4 weeks after lesion. (c-d, g-h, and k-l) Ipsilateral and contralateral sides, 12 weeks after lesion. (m)
Mean integrated density of pixels obtained ipsi and contralateral to the lesion side, 4 weeks after injury. (n)The ratio IL/CL (ipsi/contralateral
sides) of the integrated density of pixels at lamina IX, 4 weeks after lesion. (o)Mean integrated density of pixels obtained ipsi and contralateral
to the lesion side, 12 weeks after injury. (p) The ratio IL/CL (ipsi/contralateral sides) of the integrated density of pixels at lamina IX, 12 weeks
after lesion. Scale bar = 50𝜇m. Mean ± SE.
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Figure 5: Immunolabeling anti-p75NTR and S100 in sciatic nerves, 4 weeks after ventral root avulsion and repair. Increased labeling is
observed in all experimental groups as compared to control. S100: (a) intact nerve; (b, c, and d) ventral root avulsion (VRA); VRA followed
by reimplantation with fibrin sealant derived from snake venom; ventral root avulsion followed by reimplantation with commercial fibrin
sealant, respectively. p75: (e) intact nerve; (f, g, and h) ventral root avulsion (VRA); VRA followed by reimplantation with fibrin sealant
derived from snake venom; ventral root avulsion followed by reimplantation with commercial fibrin sealant, respectively. (i) Quantification
of S100 and p75NTR labeling by the integrated density of pixels. Scale bar = 50𝜇m. Mean ± SE. ∗𝑝 < 0.05.
immunostaining showed increased astrocyte reactivity after
VRA as demonstrated by the presence of GFAP-positive
activated astrocytes, particularly concentrated in the vicinity
of the avulsed motoneurons. However, the astroglial reactiv-
ity in reimplanted groups was not significantly different from
the VRA alone (VRA Only: 2.34 ± 0.22; VRA + Venom Glue:
2.08 ± 0.30; VRA + Commercial Glue: 2.26 ± 0.21, mean ratio
ipsi/contralateral ± SE; F
2,12
= 0,30; P value = 0.74;𝑁 = 5 per
group). Similar resultswere observed formicroglial reactivity,
4 weeks after lesion, where the immunostaining showed
increased microglial reaction after VRA, as demonstrated by
the presence of Iba1-positive activated microglia. In the same
way, the microglial reactivity in the reimplanted groups was
not significantly different from the VRA alone (VRA Only:
4.13±0.55; VRA + Venom Glue: 3.46±0.17; VRA + Commer-
cial Glue: 3.41±0.40;mean ratio ipsi/contralateral± SE;F
2,12
=
0.99; P value = 0.39; 𝑁 = 5 per group). In contrast, twelve
weeks after lesion, the immunostaining showed decreased
glial reactivity in all experimental groups, in comparisonwith
4 weeks survival time. Nevertheless, no significant differ-
ence between experimental groups was observed (astroglial
reactivity: VRA Only: 2.40 ± 0.27; VRA + Venom Glue:
2.34 ± 0.22; VRA + Commercial Glue: 2.33 ± 0.46; mean
ratio ipsi/contralateral ± SE; F
2,6
= 0,015; P value = 0.984;
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Figure 6: Continued.
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Figure 6: (a–d) Representative micrographs of estimated number of myelinated axons in the sciatic nerve, 4 weeks, following ventral root
avulsion and repair. (e–h) Representative micrographs of estimated number of myelinated axons in the sciatic nerve, 12 weeks, following
ventral root avulsion and repair. Scale bar = 10 𝜇m. (i–l) Frequency distribution of fiber diameter of regenerated fibers, 12 weeks, following
ventral root avulsion and repair. (m–p) Frequency distribution of 𝑔 ratio of regenerated fibers, 12 weeks, following ventral root avulsion and
repair. ∗𝑝 < 0.05; ∗∗𝑝 < 0.01; ∗∗∗𝑝 < 0.001.
𝑁 = 3 per group;microglial reactivity:VRAOnly: 2.82±0.13;
VRA + Venom Glue: 2.29 ± 0.16; VRA + Commercial Glue:
2.33 ± 0.11; mean ratio ipsi/contralateral ± SE; F
2,6
= 4.639; P
value = 0.046;𝑁 = 3 per group).Therefore, the glial reactivity
was not significantly further increased after reimplantation in
both experimental times.
3.4. Roots Reimplantation Affects Pan-Neurotrophin Receptor
(p75NTR) and S100 Expression in the Regenerating Sciatic
Nerve. Schwann cell activity (S100 labeling) and p75NTR
expression after ventral root avulsion and reimplantation
were examined in the sciatic nerve by immunofluorescence,
4 weeks after lesion (Figure 5). p75NTR is expressed on
developing motoneurons and is de novo expressed by adult
motoneurons under pathological conditions such as trauma
or degeneration. In addition, roles of Schwann cells on
the regenerative process include phagocytosis of axon and
myelin debris derived from Wallerian degeneration, being
responsible for the remyelination of axons. In this sense,
it is important to identify the effects of reimplantation on
p75NTR and S100 expression. The immunostaining revealed
an increase of such neurotrophin receptor expression after
VRA as demonstrated in Figure 5, being statistically higher in
theVRA+CommercialGlue group (VRAOnly: 1,509 ± 626.5;
VRA + Venom Glue: 2,286 ± 788.1; VRA + Commercial Glue:
3,266 ± 403.9; Control: 464.5 ± 146.1; integrated density
of pixels; mean ± SE; F
2,12
= 4.704; P value = 0.0154; 𝑁 =
5 per group). In the same way, S100 labeling showed an
increased Schwann cell activity after injury/reimplantation
in all experimental groups, being more expressive in the
VRA group (VRA Only: 8882 ± 1362; VRA + Venom Glue:
6237±754.8;VRA + Commercial Glue: 4640±536.3; Control:
3755 ± 378.1; integrated density of pixels; mean ± SE; F
2,12
=
7.099; P value = 0.0030;𝑁 = 5 per group).
3.5. Roots Reimplantation Promoted Axonal Regeneration.
The number of myelinated axons present in the sciatic nerve
was estimated based on the total area of the nerve and on
the fiber number in the evaluated fields. After 12 weeks
after injury (Figure 6), the number of myelinated axons was
higher in reimplanted groups when compared to VRA group,
showing the capacity of regeneration of motor axons after
reimplantation, allowing growth towards the target muscles
(VRA group 6,219 ± 231.4; VRA + Snake Venom Sealant
group 7,177±486.7; VRA+Commercial Sealant group 7,508±
151.5; Contralateral group 8,093 ± 305.1 mean ± SE). No
significant differences between the reimplanted groups were
observed. In addition, morphometry revealed an increase of
the myelinated fibers with thin myelin sheath in the animals
from VRA group (Figures 6(m)–6(p)). In the reimplanted
groups it was possible to notice an increased number of
myelinated fibers with thicker myelin sheath in comparison
to the VRA group, suggesting possible axonal regeneration.
Contralateral intact sciatic nerves showed normal distribu-
tion [4, 40] and greater number of fibers.
3.6. Recovery of Motor Function by Reimplantation. The
recovery of the functional recovery was evaluated using
the CatWalk system (Noldus Inc., Netherlands, Figure 7),
from the 1st until the 12th week after injury. Postoperative
assessments of peroneal functionwere performedweekly.The
preoperative peroneal functional index mean values did not
significantly differ between groups. At the first postoperative
week, all groups have shown drastic decrease in mean PFI,
indicating functional loss. Nevertheless, at the 12th postop-
erative week, the reimplanted groups presented significantly
higher mean PFI compared to the VRA group, according to
the formula described by Bain et al. [35]. Statistical analysis
revealed no differences between the reimplanted groups.
Furthermore, these results are consistent with the footprint
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Figure 7: Motor function recovery up to 12 weeks after lesion (0 = preoperative). (a) Graph of the duration of contact of a paw with the glass
plate in a step cycle (seconds). (b) Graph of the surface area of the complete print (cm3). (c) Graph of the peroneal nerve functional index.
Observe the significantly improvement of motor performance in the fibrin sealant reimplanted groups compared to VRA Only from the first
week after lesion until the twelfth week. A significant restoration of weight-bearing capacity following avulsion and reimplantation with the
fibrin sealants is also observed. Values are expressed as the ratio IL/CL (ipsi/contralateral sides) pressure exerted by the paw on the CatWalk
platform. ∗∗𝑝 < 0.01.
paw pressure data indicating that the reimplanted groups per-
formed better in supporting their body weight on the injured
limb (Figure 8; see Supplementary Videos 1–4 in Supplemen-
taryMaterial available online at http://dx.doi.org/10.1155/2016/
2932784).
4. Discussion
Development of new strategies for treating spinal root
avulsion is of great medical relevance. Experimentally, it
is possible to mimic human brachial plexus lesions by
disconnecting ventral roots from the surface of the spinal
cord. The result is ipsilateral limb paralysis, with absence
of spontaneous recovery. We have previously suggested a
root reimplantation method, by apposing avulsed roots to
the lesion site, stabilizing the repair by the application of a
fibrin scaffold, derived from nonhuman blood [2]. Here we
compare such restoration performance and functional recov-
ery with a commercial fibrin sealant Tissucol (Baxter AG,
Vienna, Austria), analyzing data 4 and 12 weeks after surgery.
Ventral root avulsion results in significant spinal moto-
neuron degeneration (MN), combined with glial reactivity
and synaptic circuits shrinkage [41]. It is known that such
proximal lesion induces loss of about 80% of axotomized
motoneurons during the first 2 weeks after the injury
[7, 42, 43]. In this aspect, the present data allow concluding
that reimplantation of avulsed roots is neuroprotective by
itself. After 4 weeks of injury a lower rate of neuronal death
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Figure 8: Paw print and walking profile, obtained with the CatWalk system, at 12 weeks after lesion. (a–c) Preoperative; (d–f) VRA Only;
(g–i) VRA followed by reimplantation with fibrin sealant derived from snake venom; (j–l) ventral root avulsion followed by reimplantation
with commercial fibrin sealant. Observe rats from reimplanted groups using the right paw, whereas the avulsed rat without root repair cannot
control the lesioned limb. A significant restoration of weight-bearing capacity following avulsion and reimplantation with the fibrin sealants
was also observed.
was observed, regardless the fibrin glue employed for the
root repair. Further, reimplanting neuroprotective effects
were long-lasting, as they were present at the same levels
up to 12 weeks after injury. These findings are in line with
Hallin and contributors [44] that suggested motoneuron
survival after root repair is based on neurotrophic factor
production by glial cells at the CNS/PNS interface. This
has also been connected to the breakage of the blood-brain
barrier, allowing neurotrophic factor producing immune
cells to enter spinal cord gray matter environment [45–47].
Nevertheless, Eggers et al. [48] demonstrated that roots
repair is unable to completely hampers neurodegeneration.
Besides neuronal death, a hallmark of VRA is the reduc-
tion of presynaptic terminals to motoneurons. Such process
decreases or even abolishes synaptic transmission [11–13]. In
agreement with the literature, we observed extensive synaptic
loss after avulsion without reimplantation. Importantly, the
groups that were subjected to root repair showed significant
preservation of synapses when compared to the avulsion
alone. Therefore, it is possible that early reparation of lesion
stabilizes spinal circuits in an inhibition/excitation propor-
tion compatible with preservation of regenerating neurons.
Coupled with the above discussed synaptic changes, glial
cells become reactive following VRA. Such reactive gliosis is
characterized by hypertrophy of the cell body and processes
of astrocytes and microglial hyperplasia [49–51]. This in
turn may result in scar formation, inhibiting axonal growth
[52], or lead to neurotrophic support of the axotomized
neurons, resulting in regeneration. Reimplantation of ventral
roots did not significantly decrease microglial and astroglial
reactivity, four weeks after lesion. Ohlsson et al. [53] also did
not observe differences in astroglial and microglial reaction,
when comparing avulsed and reimplanted groups, at the
same time point following lumbosacral ventral root avulsion
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injury. We believe that glial reaction following root repair
did not hamper axonal sprouting, based on morphological
evaluation of the sciatic nerve 12 weeks after lesion, as well
as on behavioral assessment. Further, in order to achieve
such gliosis downregulation, association with pharmacologi-
cal/cell therapy approaches seems to be necessary.
The Wallerian degeneration processes that follow prox-
imal axotomy became clear at the ipsilateral sciatic nerve,
already at 4 weeks after injury, by the significant decrease
in number of myelinated axons, combined with diminished
mean values of myelin sheath, compatible to what has been
described previously [7, 54]. On the contrary, 12 weeks
after repair revealed improved number of fibers, indicating
regeneration, regardless the fibrin sealant used. In the same
fashion, myelin thickness and “𝑔” ratio reach close to normal
values in reimplanted groups, similar to what has been shown
in the literature [40, 55].Thus, root reimplantation has proven
to be essential for the axon regrowth, allowing CNS/PNS
reconnection towards target muscle fibers.
Importantly, the regeneration process followed by avulsed
root repair must be evidenced via behavioral improvement
by motor and gait recovery. In this sense, the use of a refined
system to investigate the motor capacity can provide reliable
data on animals’ functional recovery [56, 57]. The mostly
automatic walking track analysis, by the CatWalk system,
has been recently introduced and proven to deliver highly
precise data onmobility deficit/recovery detection, including
the following parameters: footprint area, footprint pressure
intensity, position, and footstep duration [58]. Our results
demonstrated that motor function loss is evidenced imme-
diately after injury (first week after operation), reflecting
denervation of target muscles, corresponding to the territory
of the sciatic nerve. Since axonal regrowth is a slow process,
observation of long-term survival times is of fundamental
importance. Herein we show evidence of recovery by the 8th
week after repair. Best behavioral values were observed after
12 weeks following root reimplantation. Such motor recovery
possibly involved plasticity of the nervous system at different
levels, including motor cortex and descending pathways as
well as motor unit refinement [59].
Overall, the present work demonstrates that fibrin sealant
based restoration of avulsed roots is efficient and results in
neuroprotection of proximally axotomizedmotoneurons and
motor recovery. Also, our findings indicate similar regen-
erative performance of both biological adhesives employed,
highlighting the significant potential of the nonhuman
derived glue produced by CEVAP, Brazil.
5. Conclusions
The fibrin sealant obtained from the Crotalus durissus terrifi-
cus venom as well as the commercial fibrin sealant Tissucol
(Baxter AG, Vienna, Austria) performed equally well for
the restoration of CNS/PNS interface, following ventral root
avulsion lesion. The data herein indicate that such surgical
approach is neuroprotective, but a critical recovery timeframe
of at least 8 weeks after surgery is necessary, reaching stable
motor function by 12 weeks after operation.
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